BridgeBio Pharma to Discuss Phase 2B Data and Phase 3 Trial Design for Encaleret in ADH1 06.13.2022 at 4:30 PM EDT Click here for webcast Supporting Materials BBIO – ADH1 Encaleret Phase 2b Results Investor Webcast 2.3 MB